These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22988803)

  • 1. [The application of synthetic peptides to characterize the site-directed antiviral humoral immune response in patients with respiratory syncytial viral infection].
    Krivitskaia VZ; Somonina AA; Voĭtsekhovskaia EM; Amosova IV; Mil'kint KK; Sukhovetskaia VF; Golovacheva EG; L'vov NI; Vlasov GP
    Klin Lab Diagn; 2012 Jul; (7):42-5. PubMed ID: 22988803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells.
    Cortjens B; Yasuda E; Yu X; Wagner K; Claassen YB; Bakker AQ; van Woensel JBM; Beaumont T
    J Virol; 2017 May; 91(10):. PubMed ID: 28275185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The age-related specificity of site-oriented immunity in respiratory-syncytial virus infection].
    Krivitskaia VZ; Sominina AA; Vlasov GP; Sukhovetskaia VF; Golovanova AK
    Vopr Virusol; 2004; 49(4):25-9. PubMed ID: 15293508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses against epitopes on the F protein of bovine respiratory syncytial virus differ in infected or vaccinated cattle.
    Schrijver RS; Hensen EJ; Langedijk JP; Daus F; Middel WG; Kramps JA; van Oirschot JT
    Arch Virol; 1997; 142(11):2195-210. PubMed ID: 9672586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children.
    Freitas GR; Silva DA; Yokosawa J; Paula NT; Costa LF; Carneiro BM; Ribeiro LZ; Oliveira TF; Mineo JR; Queiróz DA
    J Med Virol; 2011 Oct; 83(10):1826-33. PubMed ID: 21837801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease.
    Lee YN; Hwang HS; Kim MC; Lee YT; Lee JS; Moore ML; Kang SM
    Antiviral Res; 2015 Mar; 115():1-8. PubMed ID: 25513755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin-class-specific immune response to respiratory syncytial virus structural proteins in infants, children, and adults.
    Popow-Kraupp T; Lakits E; Kellner G; Kunz C
    J Med Virol; 1989 Mar; 27(3):215-23. PubMed ID: 2723614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of human antibodies against linear antigenic and immunogenic regions of respiratory syncytial virus (RSV) nucleocapsid and phospho-proteins shows the site-directed characteristics.
    Leonova IV; Leonov SV; Waris M; Russi JC; Grandien M; Norrby E
    J Clin Virol; 1998 Aug; 11(2):137-47. PubMed ID: 9785215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of subgroup-specific peptides of the G protein of respiratory syncytial virus for characterization of the immune response.
    Akerlind-Stopner B; Utter G; Norrby E; Mufson MA
    J Med Virol; 1995 Oct; 47(2):120-5. PubMed ID: 8830114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults.
    Walsh EE; Falsey AR
    J Infect Dis; 2004 Jul; 190(2):373-8. PubMed ID: 15216475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice.
    Bian C; Liu S; Liu N; Zhang G; Xing L; Song Y; Duan Y; Gu H; Zhou Y; Zhang P; Li Z; Zhang K; Wang Z; Zhang S; Wang X; Yang P
    Antiviral Res; 2014 Apr; 104():110-7. PubMed ID: 24509239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
    Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
    J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of linear epitopes recognised by the primary human antibody response to a variable region of the attachment (G) protein of respiratory syncytial virus.
    Cane PA
    J Med Virol; 1997 Apr; 51(4):297-304. PubMed ID: 9093944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
    López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection.
    Jounai N; Yoshioka M; Tozuka M; Inoue K; Oka T; Miyaji K; Ishida K; Kawai N; Ikematsu H; Kawakami C; Shimizu H; Mori M; Ishii KJ; Takeshita F
    EBioMedicine; 2017 Feb; 16():124-135. PubMed ID: 28111238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
    Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
    PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subgroup specific protection of mice from respiratory syncytial virus infection with peptides encompassing the amino acid region 174-187 from the G glycoprotein: the role of cysteinyl residues in protection.
    Simard C; Nadon F; Séguin C; Thien NN; Binz H; Basso J; Laliberté JF; Trudel M
    Vaccine; 1997 Mar; 15(4):423-32. PubMed ID: 9141214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins.
    Fuentes S; Coyle EM; Beeler J; Golding H; Khurana S
    PLoS Pathog; 2016 Apr; 12(4):e1005554. PubMed ID: 27100289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of the humoral immune response on the pathogenesis of respiratory syncytial virus (RSV) infection].
    Streckert HJ; Humbert B; Philippou S; Forster J
    Immun Infekt; 1993 Jun; 21(3):75-7. PubMed ID: 8335338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Epitope-Specific Respiratory Syncytial Virus Vaccine Based on an Antibody Scaffold.
    Luo X; Liu T; Wang Y; Jia H; Zhang Y; Caballero D; Du J; Wang RE; Wang D; Schultz PG; Wang F
    Angew Chem Int Ed Engl; 2015 Nov; 54(48):14531-4. PubMed ID: 26434555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.